User blogs

Several Vaccine developers have demonstrated a preference of incorporating vaccine adjuvants owing to various advantages offered by such agents, including the increased efficacy of existing vaccines. The vaccine adjuvants marketis estimated to be worth $4.3 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 2.7% during the forecast period. Vaccines have enabled the prevention of more than 37 million deaths due to various disease indications, such as cholera, diphtheria, influenza, tetan... more